Inoperable/Recurrent Endometrial Cancer and Building a Brachytherapy Practice in a Community Setting (PRO 06)
Recurrent and inoperable endometrial cancer can be challenging to manage, both from a decision-making standpoint (palliative versus curative intent) and technically. In this activity, attendees can gain greater access to understanding of patient selection and practical aspects of radiation for recurrent and inoperable endometrial cancer patients. Providers wishing to expand their gynecologic brachytherapy programs can engage about common pitfalls and learn ways to safely enhance their skills.
This activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, radiation dosimetrists and residents.
Upon completion of this live activity, participants should be able to do the following:
- Assess their existing brachytherapy capabilities for treatment of gynecologic cancers and evaluate ways to enhance access and capabilities in a community setting.
- Select patients for appropriate treatment of recurrent or inoperable endometrial cancer and navigate anatomic or technical challenges to provide quality radiation care.
Malolan S. Rajagopalan, MD, MBA, is employed by Mount Carmel Health System. Dr. Rajagopalan is a Partner with Radiology, Inc. and holds an uncompensated position with the University of Pittsburgh Department of Radiation Oncology. He receives compensation from Varian.
J. Spencer Thompson, MD, is employed by University of Oklahoma Health Sciences Center and Stephenson Cancer Center.
Emma Charlotte Fields, MD, is employed by Virginia Commonwealth University Health System, Massey Cancer Center.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.